Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 739: Line 739:
 
|Mixed-phenotype acute leukaemia with BCR::ABL1 fusion
 
|Mixed-phenotype acute leukaemia with BCR::ABL1 fusion
 
|Disease
 
|Disease
−
|Tracy Tucker, PhD, FCCMG
+
|
 
|
 
|
 
|
 
|
Line 748: Line 748:
 
|
 
|
 
|
 
|
−
|
+
|Tracy Tucker, PhD, FCCMG
 
|
 
|
 
|
 
|
Line 755: Line 755:
 
|Mixed-phenotype acute leukaemia with KMT2A rearrangement
 
|Mixed-phenotype acute leukaemia with KMT2A rearrangement
 
|Disease
 
|Disease
−
|Tracy Tucker, PhD, FCCMG
+
|
 
|
 
|
 
|
 
|
Line 764: Line 764:
 
|
 
|
 
|
 
|
−
|
+
|Tracy Tucker, PhD, FCCMG
 
|
 
|
 
|
 
|
Line 787: Line 787:
 
|Mixed-phenotype acute leukaemia, B/myeloid
 
|Mixed-phenotype acute leukaemia, B/myeloid
 
|Disease
 
|Disease
−
|Priyatharsini Nirmalanantham, MD and  Shashi Shetty, PhD
+
|
 
|
 
|
 
|
 
|
Line 796: Line 796:
 
|
 
|
 
|
 
|
−
|
+
|Priyatharsini Nirmalanantham, MD and  Shashi Shetty, PhD
 
|
 
|
 
|
 
|
Line 803: Line 803:
 
|Mixed-phenotype acute leukaemia, T/myeloid
 
|Mixed-phenotype acute leukaemia, T/myeloid
 
|Disease
 
|Disease
−
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
+
|
 
|
 
|
 
|
 
|
Line 812: Line 812:
 
|
 
|
 
|
 
|
−
|
+
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
 
|
 
|
 
|
 
|
Line 819: Line 819:
 
|Mixed-phenotype acute leukaemia, rare types
 
|Mixed-phenotype acute leukaemia, rare types
 
|Disease
 
|Disease
−
|Elicia Goodale, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
+
|
 
|
 
|
 
|
 
|
Line 828: Line 828:
 
|
 
|
 
|
 
|
−
|
+
|Elicia Goodale, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
 
|
 
|
 
|
 
|
Line 851: Line 851:
 
|Acute undifferentiated leukaemia
 
|Acute undifferentiated leukaemia
 
|Disease
 
|Disease
−
|Amelia Nakanishi, MD and Shashi Shetty, PhD
+
|
 
|
 
|
 
|
 
|
Line 860: Line 860:
 
|
 
|
 
|
 
|
−
|
+
|Amelia Nakanishi, MD and Shashi Shetty, PhD
 
|
 
|
 
|
 
|
Line 901: Line 901:
 
|Blastic plasmacytoid dendritic cell neoplasm
 
|Blastic plasmacytoid dendritic cell neoplasm
 
|Disease
 
|Disease
−
|Hao Liu, MD and Daynna J. Wolff, PhD
+
|
 
|
 
|
 
|
 
|
Line 910: Line 910:
 
|
 
|
 
|
 
|
−
|
+
|Hao Liu, MD and Daynna J. Wolff, PhD
 
|
 
|
 
|
 
|
Line 917: Line 917:
 
|Langerhans cell histiocytosis
 
|Langerhans cell histiocytosis
 
|Disease
 
|Disease
−
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
+
|
 
|
 
|
 
|
 
|
Line 926: Line 926:
 
|
 
|
 
|
 
|
−
|
+
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
 
|
 
|
 
|
 
|
Line 933: Line 933:
 
|Langerhans cell sarcoma
 
|Langerhans cell sarcoma
 
|Disease
 
|Disease
−
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
+
|
 
|
 
|
 
|
 
|
Line 942: Line 942:
 
|
 
|
 
|
 
|
−
|
+
|Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
 
|
 
|
 
|
 
|
Line 1,045: Line 1,045:
 
|Histiocytic sarcoma
 
|Histiocytic sarcoma
 
|Disease
 
|Disease
−
|Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic
+
|
 
|
 
|
 
|
 
|
Line 1,054: Line 1,054:
 
|
 
|
 
|
 
|
−
|
+
|Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic
 
|
 
|
 
|
 
|
Line 1,073: Line 1,073:
 
|
 
|
 
|
 
|
 +
----<br />
 
|
 
|
 
|
 
|
Line 1,143: Line 1,144:
 
|KSHV/HHV8-associated multicentric Castleman disease
 
|KSHV/HHV8-associated multicentric Castleman disease
 
|Disease
 
|Disease
−
|Sudha Arumugam, MD
+
|
 
|
 
|
 
|
 
|
Line 1,152: Line 1,153:
 
|
 
|
 
|
 
|
−
|
+
|Sudha Arumugam, MD
 
|
 
|
 
|
 
|
Line 1,175: Line 1,176:
 
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
 
|B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
 
|Disease
 
|Disease
−
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,184: Line 1,185:
 
|
 
|
 
|
 
|
−
|
+
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
 
|
 
|
 
|
 
|
Line 1,191: Line 1,192:
 
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy
 
|B-lymphoblastic leukaemia/lymphoma with hypodiploidy
 
|Disease
 
|Disease
−
|Ashwini Yenamandra PhD FACMG  Lisa Smith PhD FACMG  Yassmine Akkari PhD FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,200: Line 1,201:
 
|
 
|
 
|
 
|
−
|
+
|Ashwini Yenamandra PhD FACMG  Lisa Smith PhD FACMG  Yassmine Akkari PhD FACMG
 
|
 
|
 
|
 
|
Line 1,207: Line 1,208:
 
|B-lymphoblastic leukaemia/lymphoma with iAMP21
 
|B-lymphoblastic leukaemia/lymphoma with iAMP21
 
|Disease
 
|Disease
−
|Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte
+
|
 
|
 
|
 
|
 
|
Line 1,216: Line 1,217:
 
|
 
|
 
|
 
|
−
|
+
|Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte
 
|
 
|
 
|
 
|
Line 1,223: Line 1,224:
 
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
 
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
 
|Disease
 
|Disease
−
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,232: Line 1,233:
 
|
 
|
 
|
 
|
−
|
+
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
 
|
 
|
 
|
 
|
Line 1,239: Line 1,240:
 
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
 
|B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
 
|Disease
 
|Disease
−
|Mark G. Evans, MD, University of California, Irvine  Fabiola Quintero-Rivera, MD, University of California, Irvine
+
|
 
|
 
|
 
|
 
|
Line 1,248: Line 1,249:
 
|
 
|
 
|
 
|
−
|
+
|Mark G. Evans, MD, University of California, Irvine  Fabiola Quintero-Rivera, MD, University of California, Irvine
 
|
 
|
 
|
 
|
Line 1,255: Line 1,256:
 
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
 
|B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
 
|Disease
 
|Disease
−
|Yassmine Akkari  Nicolas Millan
+
|
 
|
 
|
 
|
 
|
Line 1,264: Line 1,265:
 
|
 
|
 
|
 
|
−
|
+
|Yassmine Akkari  Nicolas Millan
 
|
 
|
 
|
 
|
Line 1,271: Line 1,272:
 
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
 
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
 
|Disease
 
|Disease
−
|Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG  Cancer Category/Type    B-Lymphoblastic Leukemia/Lymphoma
+
|
 
|
 
|
 
|
 
|
Line 1,280: Line 1,281:
 
|
 
|
 
|
 
|
−
|
+
|Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG  Cancer Category/Type    B-Lymphoblastic Leukemia/Lymphoma
 
|
 
|
 
|
 
|
Line 1,303: Line 1,304:
 
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
 
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
 
|Disease
 
|Disease
−
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
+
|
 
|
 
|
 
|
 
|
Line 1,312: Line 1,313:
 
|
 
|
 
|
 
|
−
|
+
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
 
|
 
|
 
|
 
|
Line 1,319: Line 1,320:
 
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
 
|B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
 
|Disease
 
|Disease
−
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
+
|
 
|
 
|
 
|
 
|
Line 1,328: Line 1,329:
 
|
 
|
 
|
 
|
−
|
+
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
 
|
 
|
 
|
 
|
Line 1,392: Line 1,393:
 
|
 
|
 
|
 
|
−
|
+
|ISSUE - FIX
 
|
 
|
 
|
 
|
Line 1,405: Line 1,406:
 
|
 
|
 
|-
 
|-
−
|Chronic lymphocytic leukaemia/small lymphocytic lymphoma||Disease||Jamie Nagy, PhD, University of Iowa  Honey Reddi, PhD|| || || || ||SG|| ||
+
|Chronic lymphocytic leukaemia/small lymphocytic lymphoma||Disease|| || || || || ||SG|| ||
−
|
 
 
|
 
|
 +
|Jamie Nagy, PhD, University of Iowa  Honey Reddi, PhD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Hairy cell leukaemia||Disease||*Snehal Patel, MD, PhD|| || || || ||SG|| ||
+
|Hairy cell leukaemia||Disease|| || || || || ||SG|| ||
−
|
 
 
|
 
|
 +
|*Snehal Patel, MD, PhD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Splenic marginal zone lymphoma||Disease||*Snehal Patel, MD, PhD|| || || || ||SG|| ||
+
|Splenic marginal zone lymphoma||Disease|| || || || || ||SG|| ||
−
|
 
 
|
 
|
 +
|*Snehal Patel, MD, PhD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Splenic diffuse red pulp small B-cell lymphoma||Disease||*Snehal Patel, MD, PhD|| || || || ||SG|| ||
+
|Splenic diffuse red pulp small B-cell lymphoma||Disease|| || || || || ||SG|| ||
−
|
 
 
|
 
|
 +
|*Snehal Patel, MD, PhD
 
|
 
|
 
|
 
|
Line 1,435: Line 1,436:
 
|Splenic B-cell lymphoma/leukaemia with prominent nucleoli
 
|Splenic B-cell lymphoma/leukaemia with prominent nucleoli
 
|Disease
 
|Disease
−
|*Snehal Patel, MD, PhD
+
|
 
|
 
|
 
|
 
|
Line 1,444: Line 1,445:
 
|
 
|
 
|
 
|
−
|
+
|*Snehal Patel, MD, PhD
 
|
 
|
 
|
 
|
Line 1,451: Line 1,452:
 
|Lymphoplasmacytic lymphoma
 
|Lymphoplasmacytic lymphoma
 
|Disease
 
|Disease
−
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD  Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
+
|
 
|
 
|
 
|
 
|
Line 1,460: Line 1,461:
 
|
 
|
 
|
 
|
−
|
+
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD  Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
 
|
 
|
 
|
 
|
Line 1,499: Line 1,500:
 
|Nodal marginal zone lymphoma
 
|Nodal marginal zone lymphoma
 
|Disease
 
|Disease
−
|Andrew Ly, DO and Shivani Golem, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,508: Line 1,509:
 
|
 
|
 
|
 
|
−
|
+
|Andrew Ly, DO and Shivani Golem, PhD, FACMG
 
|
 
|
 
|
 
|
Line 1,515: Line 1,516:
 
|Paediatric nodal marginal zone lymphoma
 
|Paediatric nodal marginal zone lymphoma
 
|Disease
 
|Disease
−
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD
+
|
 
|
 
|
 
|
 
|
Line 1,524: Line 1,525:
 
|
 
|
 
|
 
|
−
|
+
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD
 
|
 
|
 
|
 
|
Line 1,531: Line 1,532:
 
|In situ follicular B-cell neoplasm
 
|In situ follicular B-cell neoplasm
 
|Disease
 
|Disease
−
|Rachel D. Burnside, PhD, MBA, FACMGG
+
|
 
|
 
|
 
|
 
|
Line 1,540: Line 1,541:
 
|
 
|
 
|
 
|
−
|
+
|Rachel D. Burnside, PhD, MBA, FACMGG
 
|
 
|
 
|
 
|
Line 1,547: Line 1,548:
 
|Follicular lymphoma
 
|Follicular lymphoma
 
|Disease
 
|Disease
−
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
+
|
 
|
 
|
 
|
 
|
Line 1,556: Line 1,557:
 
|
 
|
 
|
 
|
−
|
+
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital  Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
 
|
 
|
 
|
 
|
Line 1,563: Line 1,564:
 
|Paediatric-type follicular lymphoma
 
|Paediatric-type follicular lymphoma
 
|Disease
 
|Disease
−
|*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,572: Line 1,573:
 
|
 
|
 
|
 
|
−
|
+
|*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG
 
|
 
|
 
|
 
|
Line 1,595: Line 1,596:
 
|Primary cutaneous follicle centre lymphoma
 
|Primary cutaneous follicle centre lymphoma
 
|Disease
 
|Disease
−
|Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 1,604: Line 1,605:
 
|
 
|
 
|
 
|
−
|
+
|Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG
 
|
 
|
 
|
 
|
Line 1,611: Line 1,612:
 
|In situ mantle cell neoplasm
 
|In situ mantle cell neoplasm
 
|Disease
 
|Disease
−
|Rina Kansal, MD; Versiti Blood Center of Wisconsin
+
|
 
|
 
|
 
|
 
|
Line 1,620: Line 1,621:
 
|
 
|
 
|
 
|
−
|
+
|Rina Kansal, MD; Versiti Blood Center of Wisconsin
 
|
 
|
 
|
 
|
Line 1,627: Line 1,628:
 
|Mantle cell lymphoma
 
|Mantle cell lymphoma
 
|Disease
 
|Disease
−
|* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
+
|
 
|
 
|
 
|
 
|
Line 1,636: Line 1,637:
 
|
 
|
 
|
 
|
−
|
+
|* Mahsa Khanlari, MD * Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
 
|
 
|
 
|
 
|
Line 1,643: Line 1,644:
 
|Leukaemic non-nodal mantle cell lymphoma
 
|Leukaemic non-nodal mantle cell lymphoma
 
|Disease
 
|Disease
−
|<br />
+
|
 
|
 
|
 
|
 
|
Line 1,652: Line 1,653:
 
|
 
|
 
|
 
|
−
|
+
|<br />
 
|
 
|
 
|
 
|
Line 1,673: Line 1,674:
 
|
 
|
 
|-
 
|-
−
|Diffuse large B-cell lymphoma, NOS||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC|| ||
+
|Diffuse large B-cell lymphoma, NOS||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
 
|
 
|
 
|
 
|
Line 1,687: Line 1,688:
 
|
 
|
 
|-
 
|-
−
|Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements||Disease||Kate Berry, MBBS, BBus (Hons), Pathology Queensland|| || || || ||GC|| ||
+
|Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Kate Berry, MBBS, BBus (Hons), Pathology Queensland
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|ALK-positive large B-cell lymphoma||Disease||Manando Nakasaki, MD, PhD (University of California, Irvine)  Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)|| || || || ||GC|| ||
+
|ALK-positive large B-cell lymphoma||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Manando Nakasaki, MD, PhD (University of California, Irvine)  Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Large B-cell lymphoma with IRF4 rearrangement||Disease||*Afia Hasnain, MBBS, PhD|| || || || ||GC|| ||
+
|Large B-cell lymphoma with IRF4 rearrangement||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|*Afia Hasnain, MBBS, PhD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|High grade B-cell lymphoma with 11q aberrations||Disease||Lauren Shealy, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina|| || || || ||GC|| ||
+
|High grade B-cell lymphoma with 11q aberrations||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Lauren Shealy, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
 
|
 
|
 
|
 
|
Line 1,750: Line 1,751:
 
|
 
|
 
|-
 
|-
−
|Plasmablastic lymphoma||Disease||Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)|| || || || ||GC|| ||
+
|Plasmablastic lymphoma||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary large B-cell lymphoma of immune-privileged sites||Disease||Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center|| || || || ||GC|| ||
+
|Primary large B-cell lymphoma of immune-privileged sites||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
 
|
 
|
 
|
 
|
Line 1,771: Line 1,772:
 
|
 
|
 
|-
 
|-
−
|Intravascular large B-cell lymphoma||Disease||Kate Berry, MBBS, BBus (Hons), Pathology Queensland|| || || || ||GC|| ||
+
|Intravascular large B-cell lymphoma||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Kate Berry, MBBS, BBus (Hons), Pathology Queensland
 
|
 
|
 
|
 
|
Line 1,792: Line 1,793:
 
|
 
|
 
|-
 
|-
−
|High-grade B-cell lymphoma, NOS||Disease||Aiko Otsubo, PhD, Indiana University|| || || || ||GC|| ||
+
|High-grade B-cell lymphoma, NOS||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Aiko Otsubo, PhD, Indiana University
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Burkitt lymphoma||Disease||Becky Leung, MBBS (Hons), BSc, Pathology Queensland|| || || || ||GC|| ||
+
|Burkitt lymphoma||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Becky Leung, MBBS (Hons), BSc, Pathology Queensland
 
|
 
|
 
|
 
|
Line 1,834: Line 1,835:
 
|
 
|
 
|-
 
|-
−
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories  Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)|| || || || ||GC|| ||
+
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories  Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)
 
|
 
|
 
|
 
|
Line 1,862: Line 1,863:
 
|
 
|
 
|-
 
|-
−
|Classic Hodgkin lymphoma||Disease||Patricia V. Hernandez, M.D., Washington University School of Medicine|| || || || ||GC|| ||
+
|Classic Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
−
|
 
 
|
 
|
 +
|Patricia V. Hernandez, M.D., Washington University School of Medicine
 
|
 
|
 
|
 
|
Line 1,914: Line 1,915:
 
|
 
|
 
|-
 
|-
−
|Immunoglobulin-related (AL) amyloidosis||Disease||Heather E. Williams, PhD, MS, PgD, ErCLG|| || || || ||SG
+
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|
 
|
−
|
+
|Heather E. Williams, PhD, MS, PgD, ErCLG
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Monoclonal immunoglobulin deposition disease||Disease||Chen Yang, MD, PhD, University of Michigan|| || || || ||SG
+
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|
 
|
−
|
+
|Chen Yang, MD, PhD, University of Michigan
 
|
 
|
 
|
 
|
Line 1,938: Line 1,939:
 
|
 
|
 
|-
 
|-
−
|Gamma heavy chain disease||Disease||Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA|| || || || ||SG
+
|Gamma heavy chain disease||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|
 
|
−
|
+
|Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA
 
|
 
|
 
|
 
|
Line 1,962: Line 1,963:
 
|
 
|
 
|-
 
|-
−
|Plasma cell myeloma / multiple myeloma||Disease||*Huan Mo, MD, MS *Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SG
+
|Plasma cell myeloma / multiple myeloma||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|
 
|
−
|
+
|*Huan Mo, MD, MS *Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||Sohini Anand, MBBS  Tharanga Niroshini Senaratne, PhD|| || || || ||SG
+
|Plasma cell neoplasms with associated paraneoplastic syndrome||Disease|| || || || || ||SG
 
| ||
 
| ||
 
|
 
|
−
|
+
|Sohini Anand, MBBS  Tharanga Niroshini Senaratne, PhD
 
|
 
|
 
|
 
|
Line 2,027: Line 2,028:
 
|Early T-precursor lymphoblastic leukaemia / lymphoma
 
|Early T-precursor lymphoblastic leukaemia / lymphoma
 
|Disease
 
|Disease
−
|Fei Yang, MD, FACMG, Kaiser Permanente Northwest
+
|
 
|
 
|
 
|
 
|
Line 2,036: Line 2,037:
 
|
 
|
 
|
 
|
−
|
+
|Fei Yang, MD, FACMG, Kaiser Permanente Northwest
 
|
 
|
 
|
 
|
Line 2,057: Line 2,058:
 
|
 
|
 
|-
 
|-
−
|T-large granular lymphocytic leukaemia||Disease||*Michelle Don, MD, MS|| || || || ||SK|| ||
+
|T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|*Michelle Don, MD, MS
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|NK-large granular lymphocytic leukaemia||Disease||Michelle Don, MD|| || || || ||SK|| ||
+
|NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Michelle Don, MD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Adult T-cell leukaemia/lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG  Vanderbilt University Medical Center|| || || || ||SK|| ||
+
|Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG  Vanderbilt University Medical Center
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Sezary syndrome||Disease||Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina|| || || || ||SK|| ||
+
|Sezary syndrome||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Aggressive NK-cell leukaemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD|| || || || ||SK|| ||
+
|Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Shanelle De Lancy, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|
 
|
Line 2,106: Line 2,107:
 
|
 
|
 
|-
 
|-
−
|Mycosis fungoides||Disease||Jane Scribner, MD and Daynna J. Wolff, PhD|| || || || ||SK|| ||
+
|Mycosis fungoides||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Jane Scribner, MD and Daynna J. Wolff, PhD
 
|
 
|
 
|
 
|
Line 2,120: Line 2,121:
 
|
 
|
 
|-
 
|-
−
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD|| || || || ||SK|| ||
+
|Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Theresa Spivey, MD, Shashirekha Shetty, PhD
 
|
 
|
 
|
 
|
Line 2,155: Line 2,156:
 
|
 
|
 
|-
 
|-
−
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease||Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD|| || || || ||SK|| ||
+
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
 
|
 
|
 
|
 
|
Line 2,169: Line 2,170:
 
|
 
|
 
|-
 
|-
−
|Enteropathy-associated T-cell lymphoma||Disease||*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD|| || || || ||SK|| ||
+
|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease||Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD|| || || || ||SK|| ||
+
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Intestinal T-cell lymphoma, NOS||Disease||Derick Okwan MD, PhD (Stanford Medicine, CA)  Sumire Kitahara MD (Cedars-Sinai, CA)|| || || || ||SK|| ||
+
|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Derick Okwan MD, PhD (Stanford Medicine, CA)  Sumire Kitahara MD (Cedars-Sinai, CA)
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Hepatosplenic T-cell lymphoma||Disease||*Michelle Don, MD, MS|| || || || ||SK|| ||
+
|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|*Michelle Don, MD, MS
 
|
 
|
 
|
 
|
Line 2,204: Line 2,205:
 
|
 
|
 
|-
 
|-
−
|ALK-negative anaplastic large cell lymphoma||Disease||Miguel Gonzalez Mancera, MD  Sumire Kitahara, MD  Cedars-Sinai, Los Angeles, CA|| || || || ||SK|| ||
+
|ALK-negative anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Miguel Gonzalez Mancera, MD  Sumire Kitahara, MD  Cedars-Sinai, Los Angeles, CA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Breast implant-associated anaplastic large cell lymphoma||Disease||Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD  Cedars-Sinai Medical Center|| || || || ||SK|| ||
+
|Breast implant-associated anaplastic large cell lymphoma||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD  Cedars-Sinai Medical Center
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Nodal TFH cell lymphoma, angioimmunoblastic-type||Disease||* Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG|| || || || ||SK|| ||
+
|Nodal TFH cell lymphoma, angioimmunoblastic-type||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|* Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG
 
|
 
|
 
|
 
|
Line 2,232: Line 2,233:
 
|
 
|
 
|-
 
|-
−
|Nodal TFH cell lymphoma, NOS||Disease||Hans Magne Hamnvåg, MD  Kamran Mirza, MD, PhD|| || || || ||SK|| ||
+
|Nodal TFH cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|Hans Magne Hamnvåg, MD  Kamran Mirza, MD, PhD
 
|
 
|
 
|
 
|
Line 2,281: Line 2,282:
 
|
 
|
 
|-
 
|-
−
|Systemic EBV-positive T-cell lymphoma of childhood||Disease||*Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA|| || || || ||SK|| ||
+
|Systemic EBV-positive T-cell lymphoma of childhood||Disease|| || || || || ||SK|| ||
−
|
 
 
|
 
|
 +
|*Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA
 
|
 
|
 
|
 
|
Line 2,308: Line 2,309:
 
|Follicular dendritic cell sarcoma
 
|Follicular dendritic cell sarcoma
 
|Disease
 
|Disease
−
|Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG
+
|
 
|
 
|
 
|
 
|
Line 2,317: Line 2,318:
 
|
 
|
 
|
 
|
−
|
+
|Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG
 
|
 
|
 
|
 
|

Revision as of 09:23, 20 December 2023

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
Disease (5th Edition) Page Type Author (5th Edition) (Note: please indicate trainees in parentheses) Date Assigned to Author (5th Edition) Target Completion Date (5th Edition) Content Status (5th Edition)(Pending or Complete) Date Completed by Author (5th Edition) Associate Editor Date of Last Editor Review (5th Edition) Notes (5th Edition) Correlated Prior Disease Name (4th Edition) Correlated Prior Author (4th Edition) Content Status (4th Edition)(Pending or Complete) Date of Last Editor Review (4th Edition) Notes (4th Edition)
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)


Clonal haematopoiesis Disease Fabiola Quintero-Rivera (FQR) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Clonal cytopenias of undetermined significance Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Chronic myeloid leukaemia Disease FQR Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) Complete Date page was created
Chronic neutrophilic leukaemia Disease FQR Chronic Neutrophilic Leukemia (CNL) Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally Complete Date page was created
Chronic eosinophilic leukaemia Disease FQR Chronic Eosinophilic Leukemia, Not Otherwise Specified Chelsea D. Kramish; Daynna J.Wolff complete/pending faculty review
Polycythaemia vera Disease FQR Polycythemia Vera (PV) Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center Complete
Essential thrombocythaemia Disease FQR Essential Thrombocythemia (ET) Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN Complete
Primary myelofibrosis Disease FQR Primary Myelofibrosis (PMF) T. Niroshi Senaratne, UCLA Complete 8/4/2020 before submission
Juvenile myelomonocytic leukaemia Disease FQR Juvenile Myelomonocytic Leukemia (JMML) Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology

Associate Director | Division of Molecular Pathology, Genetics and Genomics

Duke University Health System Clinical Laboratories

PENDING importing content and reference formatting FQR has emailed SR several times, last 4/20/22
Myeloproliferative neoplasm, NOS Disease FQR Myeloproliferative Neoplasm (MPN), Unclassifiable Thomas Lee, MD, PhD, University of California, Los Angeles Complete
Cutaneous mastocytosis Disease FQR Cutaneous Mastocytosis S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD Complete
Systemic mastocytosis Disease FQR Systemic Mastocytosis Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University Complete
Mast cell sarcoma Disease FQR Mast Cell Sarcoma Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL Complete
Myelodysplastic neoplasm with low blasts and 5q deletion Disease FQR Myelodysplastic Syndrome (MDS) with Isolated del(5q) Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG Complete
Myelodysplastic neoplasm with low blasts and SF3B1 mutation Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Myelodysplastic neoplasm with biallelic TP53 inactivation Disease Eric McGinnis (assigned to new 5th edition page - FQR is this reviewed?) FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Myelodysplastic neoplasm with low blasts Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Myelodysplastic neoplasm, hypoplastic Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Myelodysplastic neoplasm with increased blasts Disease FQR Myelodysplastic Syndrome (MDS) with Excess Blasts Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center Complete
Childhood myelodysplastic neoplasm with low blasts Disease FQR Refractory Cytopenia of Childhood Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center Complete
Childhood myelodysplastic neoplasm with increased blasts Disease FQR Refractory Cytopenia of Childhood Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center Complete
Chronic myelomonocytic leukaemia Disease FQR Chronic Myelomonocytic Leukemia (CMML) Linsheng Zhang, MD, PhD Complete
Myelodysplastic/myeloproliferative neoplasm with neutrophilia Disease FQR Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Linsheng Zhang, MD, PhD Complete
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis Disease FQR Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine Complete Date page was created
Myelodysplastic/myeloproliferative neoplasm, NOS Disease FQR Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia Complete
Acute promyelocytic leukaemia with PML::RARA fusion Disease Jennelle Hodge (JH)/ Malini Sathanoori (MS) Acute Promyelocytic Leukemia (APL) with PML-RARA Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. Complete 03/01/2021-MS (re-review)
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion Disease JH_MS Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Christine Bryke, MD
Beth Israel Deaconess Medical Center, Boston, MA 		Complete 04/26/2021-MS (re-review)
Acute myeloid leukaemia with CBFB::MYH11 fusion Disease JH_MS Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Christine Bryke, MD
Beth Israel Deaconess Medical Center, Boston, MA 		Complete 03/01/2021-MS (re-review)
Acute myeloid leukaemia with DEK::NUP214 fusion Disease JH_MS Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Jennelle C. Hodge, PhD, FACMG Complete 02/24/2021-MS (re-review)
Acute myeloid leukaemia with RBM15::MRTFA fusion Disease JH_MS Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Jennelle C. Hodge, PhD, FACMG Complete
Acute myeloid leukaemia with BCR::ABL1 fusion Disease JH_MS Acute Myeloid Leukemia (AML) with BCR-ABL1 Kay Weng Choy MBBS, Monash Medical Centre Complete
Acute myeloid leukaemia with KMT2A rearrangement Disease JH_MS Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. Complete 03/01/2021-MS (re-review)
Acute myeloid leukaemia with MECOM rearrangement Disease JH_MS Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Gordana Raca MD PhD, University of Southern California, Los Angeles Complete Need permission for figure? Update WHO?
Acute myeloid leukaemia with NUP98 rearrangement Disease Eric McGinnis, MD 12/20/23 JH_MS NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Acute myeloid leukaemia with NPM1 mutation Disease JH_MS Acute Myeloid Leukemia (AML) with Mutated NPM1 Xinjie Xu, PhD, FACMG Complete Add WHO reference
Acute myeloid leukaemia with CEBPA mutation Disease JH_MS Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Paul Defazio, MSc, Monash Health Complete
Acute myeloid leukaemia, myelodysplasia-related Disease JH_MS Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Fei Yang, MD, FACMG
Oregon Health & Science University 		Complete
Acute myeloid leukaemia with other defined genetic alterations Disease JH_MS NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Acute myeloid leukaemia with minimal differentiation Disease JH_MS Acute Myeloid Leukemia (AML) with Minimal Differentiation Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine Complete
Acute myeloid leukaemia without maturation Disease JH_MS Acute Myeloid Leukemia (AML) without Maturation Jennelle C. Hodge, PhD, FACMG Complete
Acute myeloid leukaemia with maturation Disease JH_MS Acute Myeloid Leukemia (AML) with Maturation Jennelle C. Hodge, PhD, FACMG Complete
Acute basophilic leukaemia Disease JH_MS Acute Basophilic Leukemia Ashwini Yenamandra PhD FACMG Complete
Acute myelomonocytic leukaemia Disease JH_MS Acute Myelomonocytic Leukemia Fei Yang, MD, FACMG
Oregon Health & Science University 		Complete
Acute monocytic leukaemia Disease JH_MS Acute Monoblastic and Monocytic Leukemia Fei Yang, MD, FACMG
Oregon Health & Science University 		Complete
Acute erythroid leukaemia Disease JH_MS Pure Erythroid Leukemia Ashwini Yenamandra PhD FACMG Complete
Acute megakaryoblastic leukaemia Disease JH_MS Acute Megakaryoblastic Leukemia (AMKL) Fei Yang, MD, FACMG
Oregon Health & Science University 		Complete
Myeloid sarcoma Disease JH_MS Myeloid Sarcoma Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine Complete
RESOLVE 4th edition AML-Related NON-WHO entities content Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 ISSUE - FIX
Myeloid neoplasm post cytotoxic therapy Disease JH_MS Therapy-Related Myeloid Neoplasms Shawn A. Silver, DO, Shashi Shetty, Ph.D. Check reference format
Myeloid neoplasms associated with germline predisposition Disease ISSUE - FIX JH_MS
Myeloid proliferations associated with Down syndrome Disease JH_MS MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO Complete (all three pages)
Myeloid/lymphoid neoplasm with PDGFRA rearrangement Disease FQR Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Jay Alden, DO Complete
Myeloid/lymphoid neoplasm with PDGFRB rearrangement Disease FQR Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD Complete
Myeloid/lymphoid neoplasm with FGFR1 rearrangement Disease FQR Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Yanna Ding, MD PhD Complete
Myeloid/lymphoid neoplasm with JAK2 rearrangement Disease ISSUE- FIX


Resolve Non-WHO entities

FQR Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff Complete
Myeloid/lymphoid neoplasm with FLT3 rearrangement Disease ISSUE - FIX FQR Acute Myeloid Leukemia (AML) with Mutated FLT3 (HAEM4:Acute Myeloid Leukemia (AML) with Mutated FLT3 ) ???No prior content on this page??? I don't think this is a WHO entity from the 4th edition.
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes Disease FQR NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior) NEW (No Prior)
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion Disease JH_MS Tracy Tucker, PhD, FCCMG
Mixed-phenotype acute leukaemia with KMT2A rearrangement Disease JH_MS Tracy Tucker, PhD, FCCMG
Acute leukaemia of ambiguous lineage with other defined genetic alterations Disease JH_MS
Mixed-phenotype acute leukaemia, B/myeloid Disease JH_MS Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD
Mixed-phenotype acute leukaemia, T/myeloid Disease JH_MS Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
Mixed-phenotype acute leukaemia, rare types Disease JH_MS Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina
Acute leukaemia of ambiguous lineage, NOS Disease JH_MS
Acute undifferentiated leukaemia Disease JH_MS Amelia Nakanishi, MD and Shashi Shetty, PhD
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)


Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm Disease Greg Corboy (GC)
Blastic plasmacytoid dendritic cell neoplasm Disease GC Hao Liu, MD and Daynna J. Wolff, PhD
Langerhans cell histiocytosis Disease GC Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
Langerhans cell sarcoma Disease GC Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland
Indeterminate dendritic cell tumour Disease GC
Interdigitating dendritic cell sarcoma Disease GC
Juvenile xanthogranuloma Disease GC
Erdheim-Chester disease Disease GC
Rosai-Dorfman Disease Disease GC
ALK-positive histiocytosis Disease GC
Histiocytic sarcoma Disease GC Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)



Reactive B-cell rich lymphoid proliferations that can mimic lymphoma Disease GC
IgG4-related disease Disease GC
Unicentric Castleman disease Disease GC
Idiopathic multicentric Castleman disease Disease GC
KSHV/HHV8-associated multicentric Castleman disease Disease GC Sudha Arumugam, MD
B-lymphoblastic leukaemia/lymphoma Disease Holli Drendel (HD)
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy Disease HD Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
B-lymphoblastic leukaemia/lymphoma with hypodiploidy Disease HD Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG
B-lymphoblastic leukaemia/lymphoma with iAMP21 Disease HD Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion Disease HD Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features Disease HD Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement Disease HD Yassmine Akkari Nicolas Millan
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion Disease HD Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features Disease HD
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion Disease HD Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion Disease HD Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion Disease HD
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations Disease HD
B-lymphoblastic leukaemia/lymphoma, NOS Disease HD
RESOLVE 4th edition ALL-Related NON-WHO entities content B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) ISSUE - FIX ISSUE - FIX
Monoclonal B-cell lymphocytosis Disease Shivani Golem (SG)
Chronic lymphocytic leukaemia/small lymphocytic lymphoma Disease SG Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD
Hairy cell leukaemia Disease SG *Snehal Patel, MD, PhD
Splenic marginal zone lymphoma Disease SG *Snehal Patel, MD, PhD
Splenic diffuse red pulp small B-cell lymphoma Disease SG *Snehal Patel, MD, PhD
Splenic B-cell lymphoma/leukaemia with prominent nucleoli Disease SG *Snehal Patel, MD, PhD
Lymphoplasmacytic lymphoma Disease SG Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue Disease SG
Primary cutaneous marginal zone lymphoma Disease SG
Nodal marginal zone lymphoma Disease SG Andrew Ly, DO and Shivani Golem, PhD, FACMG
Paediatric nodal marginal zone lymphoma Disease SG * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD
In situ follicular B-cell neoplasm Disease SG Rachel D. Burnside, PhD, MBA, FACMGG
Follicular lymphoma Disease SG Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
Paediatric-type follicular lymphoma Disease SG *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG
Duodenal-type follicular lymphoma Disease SG
Primary cutaneous follicle centre lymphoma Disease SG Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG
In situ mantle cell neoplasm Disease SG Rina Kansal, MD; Versiti Blood Center of Wisconsin
Mantle cell lymphoma Disease SG * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
Leukaemic non-nodal mantle cell lymphoma Disease SG
Transformations of indolent B-cell lymphomas Disease SG
Diffuse large B-cell lymphoma, NOS Disease GC Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
T-cell/histiocyte-rich large B-cell lymphoma Disease GC
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements Disease GC Kate Berry, MBBS, BBus (Hons), Pathology Queensland
ALK-positive large B-cell lymphoma Disease GC Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine)
Large B-cell lymphoma with IRF4 rearrangement Disease GC *Afia Hasnain, MBBS, PhD
High grade B-cell lymphoma with 11q aberrations Disease GC Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina
Lymphomatoid granulomatosis Disease GC
EBV-positive diffuse large B-cell lymphoma Disease GC
Diffuse large B-cell lymphoma associated with chronic inflammation Disease GC
Fibrin-associated large B-cell lymphoma Disease GC
Fluid overload-associated large B-cell lymphoma Disease GC
Plasmablastic lymphoma Disease GC Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine)
Primary large B-cell lymphoma of immune-privileged sites Disease GC Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center
Primary cutaneous diffuse large B-cell lymphoma, leg type Disease GC
Intravascular large B-cell lymphoma Disease GC Kate Berry, MBBS, BBus (Hons), Pathology Queensland
Primary mediastinal large B-cell lymphoma Disease GC
Mediastinal grey zone lymphoma Disease GC
High-grade B-cell lymphoma, NOS Disease GC Aiko Otsubo, PhD, Indiana University
Burkitt lymphoma Disease GC Becky Leung, MBBS (Hons), BSc, Pathology Queensland
Primary effusion lymphoma Disease GC
KSHV/HHV8-positive diffuse large B-cell lymphoma Disease GC
KSHV/HHV8-positive germinotropic lymphoproliferative disorder Disease GC
Hyperplasias arising in immune deficiency/dysregulation Disease GC
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation Disease GC Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI)
EBV-positive mucocutaneous ulcer Disease GC
Lymphomas arising in immune deficiency / dysregulation Disease GC
Inborn error of immunity-associated lymphoid proliferations and lymphomas Disease GC
Classic Hodgkin lymphoma Disease GC Patricia V. Hernandez, M.D., Washington University School of Medicine
Nodular lymphocyte predominant Hodgkin lymphoma Disease GC
Cold agglutinin disease Disease SG
IgM monoclonal gammopathy of undetermined significance Disease SG
Non-IgM monoclonal gammopathy of undetermined significance Disease SG
Monoclonal gammopathy of renal significance Disease SG
Immunoglobulin-related (AL) amyloidosis Disease SG Heather E. Williams, PhD, MS, PgD, ErCLG
Monoclonal immunoglobulin deposition disease Disease SG Chen Yang, MD, PhD, University of Michigan
Mu heavy chain disease Disease SG
Gamma heavy chain disease Disease SG Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA
Alpha heavy chain disease Disease SG
Plasmacytoma Disease SG
Plasma cell myeloma / multiple myeloma Disease SG *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
Plasma cell neoplasms with associated paraneoplastic syndrome Disease SG Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)


Kikuchi-Fujimoto disease Disease Sumi Kitahara (SK)
Autoimmune lymphoproliferative syndrome Disease SK
Indolent T-lymphoblastic proliferation Disease SK
T-lymphoblastic leukaemia / lymphoma, NOS Disease HD
Early T-precursor lymphoblastic leukaemia / lymphoma Disease HD Fei Yang, MD, FACMG, Kaiser Permanente Northwest
T-prolymphocytic leukaemia Disease SK
T-large granular lymphocytic leukaemia Disease SK *Michelle Don, MD, MS
NK-large granular lymphocytic leukaemia Disease SK Michelle Don, MD
Adult T-cell leukaemia/lymphoma Disease SK Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center
Sezary syndrome Disease SK Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina
Aggressive NK-cell leukaemia Disease SK Shanelle De Lancy, MD, Shashirekha Shetty, PhD
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder Disease SK
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder Disease SK
Mycosis fungoides Disease SK Jane Scribner, MD and Daynna J. Wolff, PhD
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis Disease SK
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma Disease SK Theresa Spivey, MD, Shashirekha Shetty, PhD
Subcutaneous panniculitis-like T-cell lymphoma Disease SK
Primary cutaneous gamma/delta T-cell lymphoma Disease SK
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Disease SK
Primary cutaneous peripheral T-cell lymphoma, NOS Disease SK
Indolent T-cell lymphoma of the gastrointestinal tract Disease SK Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract Disease SK
Enteropathy-associated T-cell lymphoma Disease SK *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
Monomorphic epitheliotropic intestinal T-cell lymphoma Disease SK Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
Intestinal T-cell lymphoma, NOS Disease SK Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA)
Hepatosplenic T-cell lymphoma Disease SK *Michelle Don, MD, MS
ALK-positive anaplastic large cell lymphoma Disease SK
ALK-negative anaplastic large cell lymphoma Disease SK Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA
Breast implant-associated anaplastic large cell lymphoma Disease SK Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center
Nodal TFH cell lymphoma, angioimmunoblastic-type Disease SK * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG
Nodal TFH cell lymphoma, follicular-type Disease SK
Nodal TFH cell lymphoma, NOS Disease SK Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD
Peripheral T-cell lymphoma, NOS Disease SK
EBV-positive nodal T- and NK-cell lymphoma Disease SK
Extranodal NK/T-cell lymphoma Disease SK
Severe mosquito bite allergy Disease SK
Hydroa vacciniforme lymphoproliferative disorder Disease SK
Systemic chronic active EBV disease Disease SK
Systemic EBV-positive T-cell lymphoma of childhood Disease SK *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)


Follicular dendritic cell sarcoma Disease GC Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG
EBV-positive inflammatory follicular dendritic cell sarcoma Disease GC
Fibroblastic reticular cell tumour Disease GC
Intranodal palisaded myofibroblastoma Disease GC
Littoral cell angioma Disease GC
Splenic hamartoma Disease GC
Sclerosing angiomatoid nodular transformation (SANT) of spleen Disease GC
CHAPTER 7 (GENETIC TUMOUR SYNDROMES)


Fanconi anaemia Disease NA
Bloom syndrome Disease NA
Ataxia-telangiectasia syndrome Disease NA
RASopathies Disease NA
Retrieved from "https://ccga.io/index.php?title=HAEM5:Volunteer_Assignments_and_Opportunities&oldid=13932"